Cigna's prior authorization for GLP-1 weight loss medications typically requires documentation that the patient has a BMI of 30 or greater (or 27 or greater with qualifying comorbidity), has completed at least three months of a structured lifestyle modification program, and has not responded adequately to lifestyle changes alone
After one week of SP-1351 treatment with repeat oral dosing, several of these manifestations showed signs of reversal including normalization of thyroid hormone T4 levels, reduction in thyroid weight, and reduction of proptosis
Sharma used a large research network database and found that patients on GLP-1 agonists were 66% more likely to be diagnosed with gastroparesis than those not on the medication
Quality documentation available upon request
2.6 Skadajc zamwienie, Klient owiadcza, e: a) ukoczy 18 lat, b) nabywa Produkty wycznie do celw badawczych, analitycznych lub laboratoryjnych, c) nie zamierza stosowa Produktw u ludzi ani zwierzt, d) posiada wiedz lub dziaa w imieniu podmiotu posiadajcego wiedz niezbdn do prawidowego i bezpiecznego obchodzenia si z Produktami, e) zapozna si z opisem Produktu, informacjami bezpieczestwa oraz jeeli zostaa udostpniona kart charakterystyki Produktu
A total of 112 articles were initially identified through comprehensive database searches